Autism and cancer evidence scan finds no qualifying causal breakthrough
No new replicated causal autism finding or cancer result meeting GIB's cure standard was identified. Genetic findings, prenatal and perinatal exposures, environmental associations, surveillance changes, proposed mechanisms, and unsupported claims remain separate evidence categories.
Central finding
- No qualifying replicated autism-causation result was identified.
- No qualifying cancer cure was verified.
Evidence and limits
This is a bounded evidence scan rather than proof that no unpublished or inaccessible research exists.
- Evidence searches are constrained by publication timing and access.
Why it matters
Patients and families are harmed when preliminary associations or limited treatment results are promoted as established causes or cures.
What changed
No qualifying causal or cure-level breakthrough was verified in the reporting window.
What comes next
Replicated causal studies, preregistered trials, FDA actions, and mature survival or functional-outcome data.
U.S. strategic assessment
High interestPatients and families are harmed when preliminary associations or limited treatment results are promoted as established causes or cures.
Objectives
- Protect U.S. security, economic resilience, and citizens using measurable, lawful action.
Strategy
- Use primary records, allied coordination, market evidence, and independent verification to distinguish action from rhetoric.
Outcomes
- No result crossed the publication threshold during the window.
Risks
- Evidence searches are constrained by publication timing and access.
Sources
01Primary record